{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:56:41Z","timestamp":1768593401831,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jdcr.2025.10.022","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:15:29Z","timestamp":1763590529000},"page":"162-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pemphigus herpetiformis: A case report of response to dupilumab after failure of multiple conventional therapies"],"prefix":"10.1016","volume":"67","author":[{"given":"Fabiola","family":"Pab\u00f3n-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iancarlos","family":"Jim\u00e9nez-Sacarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Cuesta-Camu\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Nevarez-Pomales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Garc\u00eda-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Medina-Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2025.10.022_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaad.2013.11.043","article-title":"Pemphigus herpetiformis: from first description until now","volume":"70","author":"Kasperkiewicz","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2025.10.022_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/ijd.14395","article-title":"Clinical, pathologic, and immunologic features of pemphigus herpetiformis: a literature review and proposed diagnostic criteria","volume":"58","author":"Costa","year":"2019","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.10.022_bib3","first-page":"87","article-title":"A case of pemphigus herpetiformis with excellent response to mycophenolate mofetil","volume":"30","author":"S\u00e1nchez-P\u00e9rez","year":"2021","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"9","key":"10.1016\/j.jdcr.2025.10.022_bib4","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/jdv.18122","article-title":"A case of pemphigus herpetiformis successfully treated with rituximab","volume":"36","author":"Marniquet","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdcr.2025.10.022_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdcr.2024.09.009","article-title":"Pediatric pemphigus herpetiformis treated with rituximab","volume":"54","author":"Hamed","year":"2024","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.jdcr.2025.10.022_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/biom13040634","article-title":"Dupilumab in inflammatory skin diseases: a systematic review","volume":"13","author":"Olbrich","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jdcr.2025.10.022_bib7","article-title":"Rituximab, omalizumab, and dupilumab treatment outcomes in bullous pemphigoid: a systematic review","volume":"13","author":"Cao","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jdcr.2025.10.022_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/08820130902943097","article-title":"Involvement of T(H)1\/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-pemphigus vulgaris","volume":"38","author":"Satyam","year":"2009","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jdcr.2025.10.022_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdcr.2023.09.018","article-title":"Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus","volume":"42","author":"Jiang","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"12","key":"10.1016\/j.jdcr.2025.10.022_bib10","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1111\/jdv.16730","article-title":"Increased expression of in situ IL-31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL-31 family in the pathogenesis of the disease","volume":"34","author":"Morais","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625005570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625005570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:31:11Z","timestamp":1768552271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625005570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":10,"alternative-id":["S2352512625005570"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.022","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemphigus herpetiformis: A case report of response to dupilumab after failure of multiple conventional therapies","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}